Begoña Pérez‐Valderrama

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

Elena Castro, Nuria Romero-Laorden, Ángela del Pozo et al. · Journal of Clinical Oncology · 2019 · 366 citations · Full text

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

Jesús García-Donás, Albert Font, Begoña Pérez‐Valderrama et al. · The Lancet Oncology · 2017 · 50 citations

Urology, Genitourinary Cancer, Medicine +6

A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO).

Thomas Powles, James Larkin, Poulam M. Patel et al. · Journal of Clinical Oncology · 2019 · 50 citations

Urology, Oncology, Pd-l1 Inhibition +14

Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties

Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, M. Luz Flores et al. · International Journal of Molecular Sciences · 2021 · 37 citations · Full text

Urology, Oncology, Signaling Pathway +12

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

Begoña Pérez‐Valderrama, Jóse Ángel Arranz Arija, Ángel Rodríguez Sánchez et al. · Annals of Oncology · 2015 · 36 citations · Full text

Urology, Spazo Study, Genitourinary Cancer +7